(lp0
S"Insider Trading Activity Corcept Therapeutics Incorporated (NASDAQ:CORT ... Market Exclusive - Mar 21, 2017 Patrick G. Enright , Director of Corcept Therapeutics Incorporated  reportedly Sold 269,955 shares of the company's stock at an average price of 9.94 for a total transaction amount of $2,683,352.70 SEC Form.Why to Keeping Eye on IBERIABANK Corporation , Corcept Therapeutics ... - StockNewsJournalSell-Side Analyst's Predictions: Retail Opportunity Investments Corp. (ROIC ... - The USA Commerce"
p1
aS'Analyst Activity  Piper Jaffray Companies Reiterates Overweight on Corcept ... Market Exclusive - Mar 16, 2017 Today, Piper Jaffray Companies reiterated its Overweight rating on Corcept Therapeutics Incorporated  with a price target of $18.00.Corcept Therapeutics Incorporated  Soars 9.25% on March 10 - Equities.comCorcept Therapeutics Incorporated Price Volatility Hits An Escalated Level - CML News'
p2
aS'10.39 MarketWatch - Dec 21, 2009 Corcept Therapeutics Inc. Watchlist CreateCORTAlert. After Hours. Last Updated: Mar 20, 2017 5:38 p.m.. $ 10.39.'
p3
aS"Corcept Therapeutics Rose 18% in March. Here's Why. Motley Fool - Apr 6, 2016 What: Shares of Corcept Therapeutics , small-cap biopharma focused on developing products for the metabolic, psychiatric, and oncologic markets, gained more than 18% in March, according to data from S&amp;P Global Market Intelligence."
p4
aS"Corcept Therapeutics Announces Preliminary Fourth Quarter and Full-Year 2016 ... Marketwired  - Jan 30, 2017 Corcept Therapeutics Incorporated , a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol,&nbsp;...Corcept Therapeutics'  CEO Joseph Belanoff on Q4 2016 Results - Earnings ... - Seeking AlphaCorcept Therapeutics Incorporated  in Traders Focus - The Newburgh Press"
p5
aS"Corcept Therapeutics: Cushing's Syndrome Is Just The Beginning Seeking Alpha - Oct 11, 2016 Shares are up over 40% since the beginning of the year, but there's plenty of upside left based on growth in the company's core business."
p6
aS'Corcept Therapeutics Incorporated  Moves Higher on Volume Spike for March 08 Equities.com - Mar 8, 2017 Corcept Therapeutics Incorporated  traded on unusually high volume on Mar. 08, as the stock gained 3.08% to close at $9.72.Corcept Therapeutics Incorporated: Corcept Therapeutics Announces Fourth ... - The Wall Street TranscriptCorcept Therapeutics Incorporated  Recent Ownership Changes - Post Analyst'
p7
aS'Market Check: Narrowing in on Shares of Corcept Therapeutics Incorporated ... Baldwin Journal - 13 hours ago Many investors may have to work through multiple trading strategies to find one that works for them. Some individuals may be looking to monitor stock price momentum by looking at different historical data.'
p8
aS'Corcept Therapeutics Appoints Renee D. Gala to Board of Directors Marketwired  - Jun 28, 2016 MENLO PARK, CA-- - Corcept Therapeutics Incorporated , a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, psychiatric and&nbsp;...'
p9
aS'Corcept: A Profitable Biotech With A Bright Future Seeking Alpha - Jan 27, 2017 Corcept Therapeutics  is my favorite type of biotech company. It has an approved, marketed product with ramping sales, promising pipeline candidates, and is beginning to turn a profit.'
p10
a.